Skip to main content

Table 2 Main features of patients' care at the onset of candidemia

From: Comparison of albicans vs. non-albicans candidemia in French intensive care units

  Total
N = 136
Candidemia due to C. albicans
N = 78
Candidemia due to non-albicans Candida species
N = 58
P value
Recent surgery (<3 months) 75 (55.1) 43 (55.1) 32 (55.2) 0.99
   Intra-abdominal 56 (41.2) 32 (41.0) 24 (41.6) 0.95
   Vascular 9 (6.6) 6 (7.7) 3 (5.2) 0.54
Time from surgery to candidemia (days) 23.6 ± 20.7 22.6 ± 19.3 25.0 ± 22.7 0.62
Invasive mechanical ventilation 106 (77.9) 62 (79.5) 44 (75.9) 0.61
CVC 122 (89.8) 68 (87.2) 54 (93.2) 0.26
Time from CVC placement to candidemia (days) 15.2 ± 16.9 13.1 ± 14.9 17.8 ± 18.9 0.13
UC 122 (89.8) 68 (87.2) 54 (63.2) 0.26
Time from UC placement to candidemia (days) 16.4 ± 17.0 14.7 ± 16.7 18.6 ± 17.4 0.22
Prior antibiotherapy 84 (61.8) 48 (61.5) 36 (62.1) 0.95
Duration of antibiotherapy before candidemia (days) 18.2 ± 13.5 17.8 ± 14.4 18.7 ± 12.4 0.77
Previous exposure to azole agents 23 (16.9) 11 (14.1) 12 (20.7) 0.31
Vasoactive drug use 31 (22.8) 20 (25.6) 11 (19.0) 0.36
  1. Results are expressed as mean ± SD values or numbers (%) of patients. CVC: central venous catheter; UC: urinary catheter